Loading...
Loading...
Gilead Sciences, Inc.
GILD shares rose 4.3% to $117.91 as the company reported better-than-expected earnings for the second quarter and raised its FY15 sales forecast. Share volume was 8.4 million, compared to an all-day average of 10.9 million
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
